MedTrace Logo

Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors

NCT02000921 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2017-03-31

Study results available
· View outcomes & findings →

Summary

The main focus of this study is to determine the use of nicotine-containing products across the three experimental conditions. Subjects will be monitored to determine their continued use of assigned cigarettes, switching to other combusted and/or non-combusted tobacco, or cessation of all tobacco containing products.

Conditions

  • Tobacco Addiction
  • Dual Tobacco Use

Interventions

OTHER

VLNC cigarettes

Modified risk tobacco product

OTHER

Combusted Products

Options for combusted tobacco products include cigars, cigarillos, and little cigars, .

OTHER

Non-combusted products

Options for non-combusted tobacco products include smokeless tobacco, novel snus products, e-cigarettes and medicinal nicotine.

OTHER

CN cigarettes

Experimental cigarettes with conventional nicotine content.

Sponsors & Collaborators

Principal Investigators

  • Dorothy K Hatsukami, PhD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02000921 on ClinicalTrials.gov